Pulmonary Arterial Hypertension Improvement With Nutrition and Exercise (PHINE)
NCT03288025 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34
Last updated 2025-09-24
Summary
The purpose of this study is to investigate the extent to which diet and exercise may improve PAH through the modulation of insulin sensitivity. The central hypothesis is that dysregulated glucose metabolism elicits a response in PAH patients that can be modified by exercise and diet, thereby leading to improvements in pulmonary vascular disease.
Conditions
Interventions
- BEHAVIORAL
-
Nutrition and Exercise
5 times a week exercise training and biweekly diet counseling for 12 weeks.
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
The Cleveland Clinic
lead OTHER
Principal Investigators
-
Raed Dweik, MD · The Cleveland Clinic
-
Gustavo Heresi, MD · The Cleveland Clinic
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-09-27
- Primary Completion
- 2022-02-18
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Bioenergetic Effect of Pioglitazone in CLD-PH
NCT06336798 ·Status: RECRUITING ·Phase: PHASE2
-
Hydroxyurea in Pulmonary Arterial Hypertension
NCT01950585 ·Status: WITHDRAWN ·Phase: EARLY_PHASE1
-
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension
NCT04715113 ·Status: COMPLETED ·Phase: NA
-
Oxygen Treatment and Pulmonary Arterial Hypertension
NCT03683082 ·Status: UNKNOWN ·Phase: NA
-
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
NCT00832507 ·Status: TERMINATED ·Phase: PHASE2
-
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
NCT03863990 ·Status: COMPLETED
-
Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study
NCT04266197 ·Status: COMPLETED ·Phase: PHASE2
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Impact of Rehabilitation Program on PAH Patients Treated With Macitentan.
NCT03045666 ·Status: UNKNOWN ·Phase: NA
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
Hemodynamic Effects During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil
NCT04706546 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of Pulsed, Inhaled Nitric Oxide Versus Placebo in Symptomatic Subjects With PAH
NCT02725372 ·Status: TERMINATED ·Phase: PHASE3
-
Safety and Efficacy of Inhaled Treprostinil in Patients With PAH
NCT01557647 ·Status: WITHDRAWN ·Phase: PHASE3
-
Study Roles of Heavy Metals and Essential Metal Dyshomeostasis in Pulmonary Arterial Hypertension Patients
NCT04756076 ·Status: RECRUITING
-
Spironolactone for Pulmonary Arterial Hypertension
NCT01712620 ·Status: RECRUITING ·Phase: PHASE2
-
Hemodynamic Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension
NCT04697875 ·Status: COMPLETED ·Phase: NA
-
Effect of Pharmacologic Interaction Between ERAs and PDE-5 Inhibitors on Medication Serum Levels and Clinical Disease Status in Patients With PAH
NCT02484807 ·Status: COMPLETED
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
Acute Dosing of MK-8892 in Participants With Pulmonary Arterial Hypertension (PAH) (MK-8892-003)
NCT01934647 ·Status: TERMINATED ·Phase: PHASE1
-
Pilot Chart Review Study Of Sitaxentan Sodium (Thelin) In Patients With Pulmonary Arterial Hypertension (PAH)
NCT01445873 ·Status: COMPLETED
-
TEPH: Telaglenastat Efficacy in Pulmonary Hypertension
NCT07223528 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Acute Exposure to High Altitude on Exercise Capacity
NCT03637153 ·Status: COMPLETED ·Phase: NA
-
Effects of Normobaric Hypoxia During Exercise in Patients With Pulmonary Hypertension Receiving Sildenafil
NCT04697862 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Evaluate the Long-term Safety of Udenafil in Patient With PAH
NCT02304198 ·Status: COMPLETED ·Phase: PHASE2/PHASE3